Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 471.78B | -10.04%536.9B | 4.68%2.27T | 18.58%594.06B | 3.25%596.8B | -6.89%2.16T | -10.10%562.68B | -12.90%522.84B | -18.28%500.99B | 19.08%578.01B |
| Cost of revenue | 203.53B | -8.94%217.2B | 7.93%915.31B | 18.86%234.66B | 4.64%238.52B | -10.11%848.08B | -26.14%193.53B | -2.08%229.18B | -11.04%197.42B | 1.14%227.95B |
| Gross profit | 268.25B | -10.77%319.7B | 2.59%1.35T | 18.39%359.4B | 2.35%358.28B | -4.69%1.32T | 1.45%369.15B | -19.81%293.66B | -22.39%303.57B | 34.64%350.06B |
| Operating expense | 7.83B | 8.45%31.09B | -16.80%183.57B | 142.28%66.72B | 16.16%28.67B | 63.63%220.64B | 237.80%112.73B | 59.74%55.69B | -21.36%27.54B | -21.87%24.68B |
| Selling and administrative expenses | --23.3B | -4.87%30.76B | 40.49%134.51B | 13.63%27.47B | 23.98%32.34B | -9.36%95.75B | -56.81%11.8B | 34.26%33.69B | -14.00%24.17B | 3.88%26.08B |
| -General and administrative expense | --23.3B | -4.87%30.76B | 40.49%134.51B | 13.63%27.47B | 23.98%32.34B | -9.36%95.75B | -56.81%11.8B | 34.26%33.69B | -14.00%24.17B | 3.88%26.08B |
| Other operating expenses | --6.26B | -31.84%5.81B | -43.40%84.89B | 646.43%46.85B | -13.64%8.53B | 413.60%149.98B | 1,983.32%126.02B | -20.02%7.81B | -9.12%6.28B | 52.37%9.87B |
| Total other operating income | --21.72B | -55.07%5.48B | 42.79%35.83B | 160.83%7.6B | 8.14%12.19B | --25.09B | ---- | ---- | --2.91B | --11.27B |
| Operating profit | 260.42B | -12.44%288.61B | 6.49%1.17T | 6.03%292.68B | 1.30%329.61B | -12.08%1.1T | -22.42%256.43B | -28.18%237.97B | -22.49%276.03B | 42.45%325.37B |
| Net non-operating interest income (expenses) | 10.8B | 260.02%11.49B | -80.59%27.02B | -79.64%20.32B | -392.86%-7.18B | 330.82%139.19B | 634.03%113.37B | -843.16%-76.43B | 6,248.92%99.81B | -51.05%2.45B |
| Non-operating interest income | --28.06B | -8.78%31.13B | -31.21%149.49B | -59.36%48.68B | 57.22%34.13B | 235.94%217.31B | 428.16%149.46B | -470.53%-73.65B | 1,449.86%119.79B | 147.11%21.71B |
| Non-operating interest expense | --17.26B | -52.44%19.64B | 56.78%122.47B | 41.88%28.35B | 114.51%41.3B | 141.26%78.12B | 180.78%36.09B | -70.93%2.79B | 224.57%19.98B | 409.80%19.26B |
| Net investment income | ||||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | -4.35B | -30.15%35.27B | 470.07%104.83B | 162.63%27.29B | 2.18%50.49B | -88.90%18.39B | -123.97%-10.97B | 27.29%23.51B | -164.96%-43.57B | 43.70%49.42B |
| Special income (charges) | ||||||||||
| Other non-operating income (expenses) | ||||||||||
| Income before tax | 266.86B | -10.07%335.36B | 3.62%1.3T | 2.42%340.29B | -1.14%372.92B | -11.50%1.25T | -18.02%333.42B | -45.08%210.46B | -4.61%332.27B | 35.70%377.24B |
| Income tax | 194.65B | -19.56%200.56B | -6.11%864.57B | 9.49%252.92B | 11.58%249.34B | -3.23%920.81B | 37.85%275.42B | -37.63%190.91B | -11.57%231.01B | 21.21%223.47B |
| Net income | 72.21B | 9.08%134.8B | 30.57%434.24B | -13.71%87.37B | -19.63%123.58B | -28.43%332.58B | -71.97%58B | -74.63%19.55B | 16.25%101.26B | 64.23%153.77B |
| Net income continuous operations | --72.21B | 9.08%134.8B | 30.57%434.24B | -13.71%87.37B | -19.63%123.58B | -28.43%332.58B | -71.97%58B | -74.63%19.55B | 16.25%101.26B | 64.23%153.77B |
| Noncontrolling interests | 2.33B | 385.34%8.51B | -36.56%6.89B | -674.83%-3.39B | -74.85%1.75B | 200.19%10.87B | 33.70%16.68B | -126.78%-12.35B | 85.78%-437M | 2,162.13%6.97B |
| Net income attributable to the company | 69.88B | 3.66%126.29B | 32.84%427.34B | -10.76%90.76B | -17.01%121.83B | -30.23%321.71B | -78.75%41.32B | -61.34%31.9B | 12.77%101.69B | 56.22%146.8B |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 69.88B | 3.66%126.29B | 32.84%427.34B | -10.76%90.76B | -17.01%121.83B | -30.23%321.71B | -78.75%41.32B | -61.34%31.9B | 12.77%101.69B | 56.22%146.8B |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 58.72 | 8.92%105.46 | 38.93%345.31 | -7.08%72.36 | -13.86%96.82 | -26.33%248.55 | -76.85%33.4 | -58.72%24.88 | 19.69%77.87 | 65.86%112.4 |
| Diluted earnings per share | 58.66 | 8.91%105.38 | 38.93%345.07 | -7.07%72.31 | -13.86%96.76 | -26.35%248.38 | -77.24%32.8362 | -58.91%24.7625 | 19.60%77.81 | 65.75%112.33 |
| Dividend per share | 0 | 0 | 16.22%86 | 16.22%43 | 0 | 19.35%74 | 15.63%37 | 0 | 23.33%37 | 0 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |